Literature DB >> 27039332

Effects of Morphine on Behavioral Task Performance in SIV-Infected Rhesus Macaques.

Joanne K Marcario1, Gurudutt Pendyala2, Mariam Riazi1, Kandace Fleming3, Janet Marquis3, Shannon Callen4, Steven J Lisco2, Stephen C Fowler5, Paul D Cheney6, Shilpa J Buch7.   

Abstract

The abuse of opiates such as morphine in synergy with HIV infection not only exacerbates neuropathogenesis but significantly impacts behavioral attributes in HIV infected subjects. Thus, the goal of the current study was to characterize behavioral perturbations in rhesus macaques subjected to chronic morphine and SIV infection. Specifically, we assessed three behavioral tasks: motor skill (MS), forelimb force (FFT) and progressive ratio (PR) tasks. After collecting baseline control data (44 weeks) and data during the morphine-only dependency period (26 weeks), a subset of animals were productively infected with neurovirulent strains of SIVmac (R71/E17) for an additional 33 weeks. A general pattern in the results is that behavioral decline occurred with high CSF viral loads but not necessarily with high plasma viral loads. Compared to saline controls, all treated animals showed significant decreases in performance on all three behavioral tasks during the morphine-only dependency period. During the post infection period, only the morphine plus SIV group showed a significant further decline and this only occurred for the MS task. Taken together, these data demonstrate a clear effect of morphine to produce behavioral deficits and also suggest that morphine can act synergistically with SIV/HIV to exacerbate behavioral deficits.

Entities:  

Keywords:  AIDS; Behavior; Forelimb force; Morphine; Motor skill; Progressive ratio; SIV

Mesh:

Substances:

Year:  2016        PMID: 27039332      PMCID: PMC4848131          DOI: 10.1007/s11481-016-9667-8

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   4.147


  45 in total

Review 1.  Paradigms for behavioral assessment of viral pathogenesis.

Authors:  M R Weed; L H Gold
Journal:  Adv Virus Res       Date:  2001       Impact factor: 9.937

2.  Morphine potentiates HIV-1 gp120-induced neuronal apoptosis.

Authors:  Shuxian Hu; Wen S Sheng; James R Lokensgard; Phillip K Peterson
Journal:  J Infect Dis       Date:  2005-02-10       Impact factor: 5.226

3.  Chemokine expression in simian immunodeficiency virus-induced AIDS encephalitis.

Authors:  V G Sasseville; M M Smith; C R Mackay; D R Pauley; K G Mansfield; D J Ringler; A A Lackner
Journal:  Am J Pathol       Date:  1996-11       Impact factor: 4.307

Review 4.  Role of mu-opioids as cofactors in human immunodeficiency virus type 1 disease progression and neuropathogenesis.

Authors:  Anupam Banerjee; Marianne Strazza; Brian Wigdahl; Vanessa Pirrone; Olimpia Meucci; Michael R Nonnemacher
Journal:  J Neurovirol       Date:  2011-07-07       Impact factor: 2.643

5.  HIV encephalitis, proviral load and dementia in drug users and homosexuals with AIDS. Effect of neocortical involvement.

Authors:  J E Bell; R P Brettle; A Chiswick; P Simmonds
Journal:  Brain       Date:  1998-11       Impact factor: 13.501

6.  Impaired performance on a rhesus monkey neuropsychological testing battery following simian immunodeficiency virus infection.

Authors:  Michael R Weed; Lisa H Gold; Ilham Polis; George F Koob; Howard S Fox; Michael A Taffe
Journal:  AIDS Res Hum Retroviruses       Date:  2004-01       Impact factor: 2.205

Review 7.  Interactions between ageing and NeuroAIDS.

Authors:  Joanna Hellmuth; Benedetta Milanini; Victor Valcour
Journal:  Curr Opin HIV AIDS       Date:  2014-11       Impact factor: 4.283

Review 8.  Neurobiology of multiple insults: HIV-1-associated brain disorders in those who use illicit drugs.

Authors:  Jeanne E Bell; Juan-Carlos Arango; Iain C Anthony
Journal:  J Neuroimmune Pharmacol       Date:  2006-05-05       Impact factor: 4.147

Review 9.  Cognitive neuropsychology of HIV-associated neurocognitive disorders.

Authors:  Steven Paul Woods; David J Moore; Erica Weber; Igor Grant
Journal:  Neuropsychol Rev       Date:  2009-05-22       Impact factor: 7.444

Review 10.  Molecular pathology of neuro-AIDS (CNS-HIV).

Authors:  Leslie Crews; Christina Patrick; Cristian L Achim; Ian P Everall; Eliezer Masliah
Journal:  Int J Mol Sci       Date:  2009-03-11       Impact factor: 6.208

View more
  4 in total

Review 1.  HIV-1 and drug abuse comorbidity: Lessons learned from the animal models of NeuroHIV.

Authors:  Susmita Sil; Annadurai Thangaraj; Ernest T Chivero; Fang Niu; Muthukumar Kannan; Ke Liao; Peter S Silverstein; Palsamy Periyasamy; Shilpa Buch
Journal:  Neurosci Lett       Date:  2021-03-29       Impact factor: 3.197

Review 2.  Non-Human Primate Models of HIV Brain Infection and Cognitive Disorders.

Authors:  Sarah J Byrnes; Thomas A Angelovich; Kathleen Busman-Sahay; Catherine R Cochrane; Michael Roche; Jacob D Estes; Melissa J Churchill
Journal:  Viruses       Date:  2022-09-09       Impact factor: 5.818

Review 3.  HIV-associated synaptic degeneration.

Authors:  Wenjuan Ru; Shao-Jun Tang
Journal:  Mol Brain       Date:  2017-08-29       Impact factor: 4.041

Review 4.  Opioid and neuroHIV Comorbidity - Current and Future Perspectives.

Authors:  Sylvia Fitting; MaryPeace McRae; Kurt F Hauser
Journal:  J Neuroimmune Pharmacol       Date:  2020-09-02       Impact factor: 4.147

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.